MAINE MEDICAL CT RES INST has a total of 24 patent applications. Its first patent ever was published in 1998. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and agriculture are ALBERT EINSTEIN COLLEGE MEDICINE INC, UNIV LEIDEN MEDICAL CT and SUGIYAMA HARUO.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 | |
#2 | WIPO (World Intellectual Property Organization) | 8 | |
#3 | Canada | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Australia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Agriculture | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms | |
#5 | Animal care | |
#6 | Analysing materials | |
#7 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Maciag Thomas | 12 |
#2 | Prudovsky Igor | 6 |
#3 | Mandinov Lazar | 5 |
#4 | Bagala Cinzia | 5 |
#5 | Bellum Stephen | 5 |
#6 | Soldi Raffaella | 5 |
#7 | Mandinova Anna | 5 |
#8 | Linder Volkhard | 4 |
#9 | Friesel Robert | 4 |
#10 | Zimrin Ann B | 4 |
Publication | Filing date | Title |
---|---|---|
WO2015130935A1 | Culture conditions for expansion of nephron progenitor cells | |
WO2008048680A2 | Notch 2 signaling as a breast cancer suppressor pathway | |
WO2006125001A2 | Compositions and methods related to the intracellular effects of intracellular domains of delta1 and jagged1 | |
US2005147602A1 | Compositions, methods and kits relating to CTHRC1, a novel modulator of collagen matrix | |
WO2004078944A2 | Thrombin, soluble jaggedi, and trap and growth of stem cells | |
US2004071787A1 | Pharmacologic, therapeutic and diagnostic regulation of FGF-1 export | |
WO02096925A1 | Compositions and methods relating to control dna construct | |
US6630325B1 | Compositions, methods and kits relating to remodel | |
US6716974B1 | Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids |